ReviewJournal of physiology and biochemistry2025
The potential role of hydrogen sulfide-autophagy axis in diseases.
Review in Journal of physiology and biochemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Hydrogen sulfide (H2S), as a gaseous signaling molecule, assumes a pivotal role in regulating diverse physiological processes within cellular environments. Autophagy, a conserved intracellular degradation mechanism, is essential for maintaining cellular homeostasis through the removal of damaged organelles and misfolded proteins. Both H2S and autophagy display context-dependent dual roles—exerting either protective or detrimental effects depending on disease type, severity, and cellular environment. This review elucidates the intricate interplay between H2S and autophagy, focusing on their regulatory mechanisms and the impact they exert on inflammation, cancer, neurodegenerative diseases, ischemia-reperfusion injury, and metabolic disorders. We discuss how H2S modulates autophagy through signaling pathways that involve reactive oxygen species, endoplasmic reticulum stress, AMP-activated protein kinase, and the mechanistic target of rapamycin. Furthermore, we highlight the therapeutic potential of targeting the H2S-autophagy axis in the prevention and treatment of diseases. This review provides a theoretical foundation for future research that aims to harness the protective effects of H2S and autophagy while mitigating their adverse outcomes in pathological conditions.
Indexed as
Identifiers
41168639What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.